Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia
This study has been completed.
Study NCT00271817.   Last updated on December 9, 2008.
Information provided by Merck
Please refer to this study by its ClinicalTrials.gov identifier: NCT00271817
Sponsors and Collaborators
Merck
Investigators
Study Director: Medical Monitor Merck




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services